Nerve growth factor conjugates and uses thereof

Details for Australian Patent Application No. 2008339904 (hide)

Owner Cytos Biotechnology AG

Inventors Bachmann, Martin; Jennings, Gary; Rohn, Till

Agent Watermark

Pub. Number AU-A-2008339904

PCT Pub. Number WO2009/080823

Priority 07150234.8 20.12.07 EP

Filing date 22 December 2008

Wipo publication date 2 July 2009

International Classifications

C07K 14/48 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/080823 Priority application(s): WO2009/080823

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008339909-Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease

2008339902-Multitarget compounds active at a PPAR and cannabinoid receptor